Alcoholic hepatitis: towards an era of personalised management - Université de Lille Accéder directement au contenu
Article Dans Une Revue United European Gastroenterology Journal Année : 2020

Alcoholic hepatitis: towards an era of personalised management


Alcoholic hepatitis should be suspected in every patient with excessive chronic alcohol consumption and recent onset of jaundice. Diagnosis of alcoholic hepatitis is based on clinical and laboratory findings, and confirmed by a liver biopsy when available. Several scores are available to assess severity and prognosis of alcoholic hepatitis. The 1-month mortality of patients with severe alcoholic hepatitis, as defined by Maddrey's discriminant function, is 20-30%. Therefore, severe alcoholic hepatitis should be treated with a 28-day course of oral prednisolone after systematic screening for infection. In this review, we discuss diagnosis of alcoholic hepatitis, the different scores to assess severity of the disease, indications for corticosteroid therapy and alternative therapeutic options for non-responders to medical therapy.

Dates et versions

hal-04526369 , version 1 (29-03-2024)



Delphine Degre, Line Carolle Ntandja Wandji, Christophe Moreno, Alexandre Louvet. Alcoholic hepatitis: towards an era of personalised management. United European Gastroenterology Journal, 2020, United European Gastroenterology Journal, pp.2050640620945886. ⟨10.1177/2050640620945886⟩. ⟨hal-04526369⟩


3 Consultations
0 Téléchargements



Gmail Mastodon Facebook X LinkedIn More